← Back to Search

Other

Parallel placement for Breast Cancer

N/A
Waitlist Available
Led By Candace L Ward, MD, MPH
Research Sponsored by Albert Einstein Healthcare Network
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 90 days
Awards & highlights

Study Summary

This trial is testing whether in-line or perpendicular placement of Steri-Strips on breast surgery incisions affects healing. Patients' age, comorbid conditions, type of breast surgery, and treatment with pre-operative or post-operative chemotherapy or radiation therapy will be reviewed to ensure similar study groups. Steri-Strips will be allowed to fall off naturally and pictures will be taken of the incisional area at 30-day and 90-day follow-ups. A blinded, independent surgeon will grade each incision according to the modified Hollander Cosmesis Scale. Statistical analysis will be performed to determine significance of the

Eligible Conditions
  • Breast Cancer
  • Surgical Wound
  • Breast Disease
  • Scarring

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~90 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 90 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Cosmesis score 30 days
Cosmesis score 90 days
Secondary outcome measures
Surgical site infection
Wound dehiscence

Trial Design

2Treatment groups
Active Control
Group I: Parallel placementActive Control1 Intervention
Steri-strips will be placed in-line (parallel) with the surgical incision.
Group II: Perpendicular placementActive Control1 Intervention
Steri-strips will be placed perpendicular to the surgical incision.

Find a Location

Who is running the clinical trial?

Albert Einstein Healthcare NetworkLead Sponsor
64 Previous Clinical Trials
868,618 Total Patients Enrolled
Candace L Ward, MD, MPHPrincipal InvestigatorAlbert Einstein Medical Center Phialdelphia

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this experiment have any active sign-ups?

"According to updates made on clinicaltrials.gov, this research is actively recruiting patients since its original posting on the 1st of November 2020 and most recent alteration occurring on January 27th 2022."

Answered by AI

How many participants are included in this scientific exploration?

"Affirmative. The data hosted on clinicaltrials.gov verifies that the recruitment for this medical trial is still ongoing, having been posted in November of 2020 and last modified at the end of January 2022. A total 126 patients are required from two different sites."

Answered by AI
~21 spots leftby Apr 2025